Sam Brusco, Associate Editor03.29.22
Foot and ankle orthopedic firm Paragon 28 has appointed Meghan Scanlon to its board of directors. She will join the board’s compensation and quality, technology, and regulatory committees.
Scanlon has over 20 years of senior leadership experience with global medical device—she is currently senior VP and president of Boston Scientific’s Urology and Pelvic Health business as well as a member of the company’s executive committee.
She is also a member of the Boston Scientific Global Council for Inclusion, serving as executive sponsor for the PRIDE employee resource group.
“We are very excited to have Meghan join our Board of Directors,” Albert DaCosta, CEO and Cchairman of Paragon 28 told the press. “Meghan is a seasoned global medical device executive with an impressive track record of success. Meghan is also a champion for diversity and inclusion. I look forward to partnering with Meghan to advance our mission of improving foot and ankle patient outcomes.”
Before Boston Scientific, Scanlon worked at DePuy Synthes from 2000-2014.
Scanlon has over 20 years of senior leadership experience with global medical device—she is currently senior VP and president of Boston Scientific’s Urology and Pelvic Health business as well as a member of the company’s executive committee.
She is also a member of the Boston Scientific Global Council for Inclusion, serving as executive sponsor for the PRIDE employee resource group.
“We are very excited to have Meghan join our Board of Directors,” Albert DaCosta, CEO and Cchairman of Paragon 28 told the press. “Meghan is a seasoned global medical device executive with an impressive track record of success. Meghan is also a champion for diversity and inclusion. I look forward to partnering with Meghan to advance our mission of improving foot and ankle patient outcomes.”
Before Boston Scientific, Scanlon worked at DePuy Synthes from 2000-2014.